PURPOSE: To study the effect of a non-viral vector (carbosilane dendrimer) to efficiently deliver small interfering RNA to postmitotic neurons to study the function of hypoxia-inducible factor-1alpha (HIF1-alpha) during chemical hypoxia-mediated neurotoxicity. METHODS: Chemical hypoxia was induced in primary rat cortical neurons by exposure to CoCl(2). HIF1-alpha levels were determined by Western Blot and toxicity was evaluated by both MTT and LDH assays. Neurons were incubated with dendriplexes containing anti-HIF1-alpha siRNA and both uptake and HIF1-alpha knockdown efficiency were evaluated. RESULTS: We report that a non-viral vector (carbosilane dendrimer) can deliver specific siRNA to neurons and selectively block HIF1-alpha synthesis with similar efficiency to that achieved by viral vectors. Using this method, we have found that this transcription factor plays a neuroprotective role during the early phase of chemical hypoxia-mediated neurotoxicity. CONCLUSION: This work represents a proof-of-concept for the use of carbosilane dendrimers to deliver specific siRNA to postmitotic neurons to block selected protein synthesis. This indicates that this type of vector is a good alternative to viral vectors to achieve very high transfection levels in neurons. This also suggests that carbosilane dendrimers might be very useful for gene therapy.
PURPOSE: To study the effect of a non-viral vector (carbosilane dendrimer) to efficiently deliver small interfering RNA to postmitotic neurons to study the function of hypoxia-inducible factor-1alpha (HIF1-alpha) during chemical hypoxia-mediated neurotoxicity. METHODS: Chemical hypoxia was induced in primary rat cortical neurons by exposure to CoCl(2). HIF1-alpha levels were determined by Western Blot and toxicity was evaluated by both MTT and LDH assays. Neurons were incubated with dendriplexes containing anti-HIF1-alpha siRNA and both uptake and HIF1-alpha knockdown efficiency were evaluated. RESULTS: We report that a non-viral vector (carbosilane dendrimer) can deliver specific siRNA to neurons and selectively block HIF1-alpha synthesis with similar efficiency to that achieved by viral vectors. Using this method, we have found that this transcription factor plays a neuroprotective role during the early phase of chemical hypoxia-mediated neurotoxicity. CONCLUSION: This work represents a proof-of-concept for the use of carbosilane dendrimers to deliver specific siRNA to postmitotic neurons to block selected protein synthesis. This indicates that this type of vector is a good alternative to viral vectors to achieve very high transfection levels in neurons. This also suggests that carbosilane dendrimers might be very useful for gene therapy.
Authors: M E Cockman; N Masson; D R Mole; P Jaakkola; G W Chang; S C Clifford; E R Maher; C W Pugh; P J Ratcliffe; P H Maxwell Journal: J Biol Chem Date: 2000-08-18 Impact factor: 5.157
Authors: Anastasia Triantafyllou; Panagiotis Liakos; Andreas Tsakalof; Elena Georgatsou; George Simos; Sophia Bonanou Journal: Free Radic Res Date: 2006-08
Authors: Jesus F Bermejo; Paula Ortega; Louis Chonco; Ramon Eritja; Rafael Samaniego; Matthias Müllner; Ernesto de Jesus; F Javier de la Mata; Juan Carlos Flores; Rafael Gomez; Angeles Muñoz-Fernandez Journal: Chemistry Date: 2007 Impact factor: 5.236
Authors: Ronen R Leker; Frank Soldner; Ivan Velasco; Denise K Gavin; Andreas Androutsellis-Theotokis; Ronald D G McKay Journal: Stroke Date: 2006-11-22 Impact factor: 7.914
Authors: Olivia M Merkel; Meredith A Mintzer; Damiano Librizzi; Olga Samsonova; Tanja Dicke; Brian Sproat; Holger Garn; Peter J Barth; Eric E Simanek; Thomas Kissel Journal: Mol Pharm Date: 2010-08-02 Impact factor: 4.939
Authors: Kamila Białkowska; Katarzyna Miłowska; Sylwia Michlewska; Paulina Sokołowska; Piotr Komorowski; Tania Lozano-Cruz; Rafael Gomez-Ramirez; Francisco Javier de la Mata; Maria Bryszewska Journal: Int J Mol Sci Date: 2021-07-01 Impact factor: 5.923